350 rub
Journal Technologies of Living Systems №1 for 2014 г.
Article in number:
Dofamin and bulimia nevrosa: clinic and neurochemistry aspects
Keywords: bulimia nervosa vomitomania assessment of treatment efficiency dopamine
Authors:
M.S. Artemieva - Ph.D. (Med.), Associate Professor, Russian Peoples Friendship University. E-mail: msartemieva@mail.ru
A.Z. Drozdov - Dr.Sc. (Med.), Professor, Head of Neurochemistry Laboratory of V. Serbsky Institute of Social and Forensic Psychiatry (Moscow). E-mail: alex00582@yandex.ru
B.M. Kogan - Dr.Sc. (Biol.), Professor, Head of Department of Clinical and Special Psychology of Institute of Psychology, Sociology and social relationship, GBOU VPO MGPU. E-mail: alex00582@yandex.ru
T.S. Filatova - Ph.D. (Biol.), Senior Research Scientist, of V. Serbsky Institute of Social and Forensic Psychiatry. E-mail: alex00582@yandex.ru
I.A. Kovaleva - Ph.D. (Biol), Research Scientist, of V. Serbsky Institute of Social and Forensic Psychiatry. E-mail: alex00582@yandex.ru
Abstract:
Bulimia nervosa (NB) (F 50.2) usually manifistates in adolescents. Its main symptom is starvation because of pathologic thoughts about own overweight, then binge eating and self-induced vomiting. The disease caused somato-endocrinal disturbances end change of motivations, thinking and mental work capacity disorders. 30 patients with NB were observed. The 1-st group consist of vomitomanes, it was revealed increased of dopamine level, the 2-nd group was NB without vomitomania. The assessment of efficiency of treatment was made by changes in dopamine level, pathopsycologic method, EEG. The rate of dopamine in urine collected during 24-houers may be objective criteria of dynamic of disease because the patients never tell truth about their own condition. The habitude vomiting after binge eating were alike addiction and caused withdrawal syndrome. The increasing of dopamine level was en evident that there are not normalization of psychic state and may be relapse of clinical symptoms - of NB. Normalization of dopamine level usually revealed in 2 - 4 weeks of therapy. Faster improvement was revealed after using of standard therapy in the special hospital.
Pages: 13-17
References

  1. Korkina M.V., Civil'ko M.A., Marilov V.V. Nervnaya anoreksiya. M.: Mediczina. 1986. 176 s.
  2. Barinov A.M. Diagnosticheskie i prognosticheskie kriterii dinamiki sindroma nervnoj anoreksii (korrelyaczii somato-e'ndokrinny'x i psixicheskix rasstrojstv): Diss. - kand. med. nauk. M. 1982.
  3. Temirova A.R. Korrelyacziya osobennostej psixicheskix i somatonevrologicheskix rasstrojstv u bol'ny'x nervnoj anoreksiej: Diss. - kand.med.nauk. M.: RUDN. 2005. 181 s.
  4. Artem'eva M.S., Sulejmanov R.A. Nervnaya anoreksiya // Kachestvo zhizni. Mediczina. 2006. № 1 (12). Vy'p. Pogranichny'e psixicheskie rasstrojstva. S. 37-55.
  5. Dmitrieva T.B., Drozdov A.Z., Kogan B.M. Nejroximiya v psixiatrii. M.: GNC SiSP im. V.P. Serbskogo. 1998. 300 s.
  6. Kislova E.K. Bulimicheskie rasstrojstva pri nervnoj anoreksii: Diss?..kand. med. nauk. M. 2004. 218 s.
  7. Crisp C.V. et al. A controlled study of the effect of therapies aimed at adolescent and family psychopathology in anorexia nervosa // Br. J. Psychiatry. 1991. V. 9. V. 159. P. 325-333.
  8. Bruce K., Steiger H., Koerner N. et al. Bulimia nervosa with comorbid avoidant personality disorder: behavioural characteristics and serotonergic function // Psychol. Med. 2004. № 1. P. 113-124.
  9. Capasso A., Petrella C., Milano W. Pharmacological Profile of SSRIs and SNRIs in the Treatment of Eating Disorders Current // Clinical Pharmacology. 2000. V. 4. Issue 1. P. 78-83.
  10. Brukhin A.E., Souleimanov R.A., Artemieva M.S. Particularites des troubles du development et du comportement sexuel dans l-anorexie mentale // Revue medicale Suisse. 2011. № 287. V. 7. P. 633-680. P.638-643.
  11. World Health Organization International Statistical Classification of Diseases and Related Health Problems (ICD-IV-R). 1992.